VRPX

Virpax Pharmaceuticals, Inc. Common Stock

Delisted

VRPX was delisted on the 3rd of April, 2025.

11 hedge funds and large institutions have $11.4M invested in Virpax Pharmaceuticals, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$4.02M
2 +$3.6M
3 +$1.34M
4
ACM
Altium Capital Management
New York
+$1.3M
5
Two Sigma Investments
Two Sigma Investments
New York
+$123K

Top Sellers

1 -$205K
2 -$80K
3 -$48K
4
UBS Group
UBS Group
Switzerland
-$18K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$4.77M
2
$3.6M
3
$1.34M
4
$1.3M
5
$123K
6
$93K
7
$90K
8
$66K
9
$48K
10
$11K
11
$3K
12
13
14